LB Pharmaceuticals Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- LB Pharmaceuticals Inc.
- Company name
- LB Pharmaceuticals Inc.
- Organisation type
- Industry
- Registered legal name
- LB PHARMACEUTICALS INC
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001691082
Related records
Trials (6)
- 52-week Open Label Safety-Tolerability Study
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
- Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
- Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers
- Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults
- Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia